OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2026
Voltar para busca
Dado oficial do USPTO
CORENGAGER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
05/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
20/11/2024
Data de registro
31/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/03/2026
Última transação
05/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
PEISECKI, MARK A
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Corregene Biotechnology Co., Ltd.
Representantes
Priscilla Lauren Speer Bayramoglu Law Offices LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Protein in raw material form for scientific and medical research; diagnostic reagentsother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations for use in cell culturesother than for medical or veterinary purposes; chemical preparations for scientific purposesother than for medical or veterinary use; diagnostic preparations for research laboratory use; biological preparationsfor use in scientific research and developmentother than for medical or veterinary purposes; biochemical reagents used for non-medical purposes; cell culture reagents for scientific or research purposes
Classe 5
Pharmaceutical preparations for detectinganalyzingdiagnosing and treating tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergicimmune disorderTORCH infections and immunoglobulin diseases; anti-cancer preparations; diagnostic preparations for medical or veterinary purposes; medicines for human purposesmedicines for detectinganalyzingdiagnosing and treating tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergicimmune disorderTORCH infections and immunoglobulin diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; surgical implants comprised of living tissues; stem cells for medical purposes; vaccines; enzymes for medical purposes; biological preparations for medical purposes for the treatment of tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergic diseasesimmune disorderTORCH infections and immunoglobulin diseasesinfectious diseasesimmune disease and fibrosis diseases
Classe 42
Chemical research; chemical analysis; chemical diagnosis for scientific or medical purposes in the nature of chemical analysis; development and testing of chemical production methods; chemical testing and chemistry consultation services; cosmetic research; bacteriological research; biological research; medical research; medical laboratory servicesfor researchdevelopmenttestinganalysis purposes; clinical trials services for othersincluding the designmanagementmonitoringdata managementanalysisreportingregulatory compliance of clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/08/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
31/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/02/2026
PUBO
PUBLISHED FOR OPPOSITION
10/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2026
RFNT
REFUSAL PROCESSED BY IB
02/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/07/2025
RFRR
REFUSAL PROCESSED BY MPU
13/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/05/2025
CNRT
NON-FINAL ACTION WRITTEN
20/05/2025
DOCK
ASSIGNED TO EXAMINER
13/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
21/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/03/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
21/03/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CORENGAGER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.